Kamran Tabaddor
Neurological Surgery · White Plains, NYNPI 1942216510
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 151 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 10.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,036 and has fallen 87.2% since, to $133 in 2025. That places this record below the midpoint for neurological surgery clinicians in NY, where the typical reported total is $3,235.
Across 151 payments — averaging $21.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amneal Pharmaceuticals LLC$322
- Adamas Pharmaceuticals, Inc.$257
- Lundbeck LLC$235
- Kyowa Kirin, Inc.$215
- Lilly USA, LLC$214
- Otsuka America Pharmaceutical, Inc.$207
- plus $2K from 27 others
What the payments were for
- Speaking & faculty fees$281%
- Food & beverage$3,16599%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amneal Pharmaceuticals LLC | 15 | $322 |
| Adamas Pharmaceuticals, Inc. | 16 | $257 |
| Lundbeck LLC | 13 | $235 |
| Kyowa Kirin, Inc. | 9 | $215 |
| Lilly USA, LLC | 9 | $214 |
| Otsuka America Pharmaceutical, Inc. | 9 | $207 |
| Avanir Pharmaceuticals, Inc. | 8 | $160 |
| Sanofi | 7 | $154 |
| EMD Serono, Inc. | 7 | $139 |
| AbbVie | 5 | $110 |
| Biogen | 4 | $106 |
| Teva Pharmaceuticals USA, Inc. | 5 | $100 |
| Abbott | 1 | $100 |
| CSL Behring | 4 | $97 |
| SK Life Science, Inc. | 4 | $86 |
| Acadia Pharmaceuticals Inc | 5 | $79 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $71 |
| Akcea Therapeutics, Inc. | 3 | $58 |
| AstraZeneca | 2 | $56 |
| Sunovion Pharmaceuticals Inc. | 3 | $55 |
| Vertical Pharmaceuticals, LLC | 3 | $51 |
| Acorda Therapeutics, Inc | 3 | $45 |
| Grifols USA, LLC | 2 | $44 |
| UCB, Inc. | 1 | $33 |
| Neurocrine Biosciences, Inc. | 1 | $32 |
| Johnson & Johnson | 1 | $32 |
| GE HealthCare | 1 | $25 |
| Amgen | 1 | $24 |
| Mallinckrodt Hospital Products Inc. | 1 | $22 |
| Assertio Therapeutics, Inc. | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Novartis | 1 | $18 |
| Upsher-smith Laboratories LLC | 1 | $12 |
How this compares
$3,193 in reported general payments places this provider in the 45th percentile of 446 neurological surgery providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Memantine Hcl ErMemantine Hcl | 18 | $844 |
| Gabapentin | 29 | $167 |
| Levetiracetam | 22 | $132 |
| Donepezil Hcl | 23 | $116 |
| Duloxetine Hcl | 15 | $101 |
| Nortriptyline Hcl | 15 | $62 |
| Citalopram HbrCitalopram Hydrobromide | 14 | $39 |
| Sertraline Hcl | 12 | $24 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in White Plains
- Ryan DenhaeseWilliamsville$1.9M
- J MoccoNew York$1.6M
- Adnan SiddiquiWilliamsville$1.5M
- Leo HopkinsBuffalo$1.2M
- Aziz Basem QandahNew Hartford$1.1M
- Alejandro BerensteinNew York$1.1M
- Darryl LauNew York$915K
- Mark BilskyNew York$903K
- John PollinaWilliamsville$661K
- Michael GroffRochester$559K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.